Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats

Rhabdomyolysis is characterized by muscle damage and leads to acute kidney injury (AKI). Clinical and experimental studies suggest that glycogen synthase kinase 3β (GSK3β) inhibition protects against AKI basically through its critical role in tubular epithelial cell apoptosis, inflammation and fibro...

Full description

Bibliographic Details
Main Authors: Maria Heloisa Massola Shimizu, Rildo Aparecido Volpini, Ana Carolina de Bragança, Mariana Moura Nascimento, Desiree Rita Denelle Bernardo, Antonio Carlos Seguro, Daniele Canale
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934413/?tool=EBI
_version_ 1797903290764099584
author Maria Heloisa Massola Shimizu
Rildo Aparecido Volpini
Ana Carolina de Bragança
Mariana Moura Nascimento
Desiree Rita Denelle Bernardo
Antonio Carlos Seguro
Daniele Canale
author_facet Maria Heloisa Massola Shimizu
Rildo Aparecido Volpini
Ana Carolina de Bragança
Mariana Moura Nascimento
Desiree Rita Denelle Bernardo
Antonio Carlos Seguro
Daniele Canale
author_sort Maria Heloisa Massola Shimizu
collection DOAJ
description Rhabdomyolysis is characterized by muscle damage and leads to acute kidney injury (AKI). Clinical and experimental studies suggest that glycogen synthase kinase 3β (GSK3β) inhibition protects against AKI basically through its critical role in tubular epithelial cell apoptosis, inflammation and fibrosis. Treatment with a single dose of lithium, an inhibitor of GSK3β, accelerated recovery of renal function in cisplatin and ischemic/reperfusion-induced AKI models. We aimed to evaluate the efficacy of a single dose of lithium in the treatment of rhabdomyolysis-induced AKI. Male Wistar rats were allocated to four groups: Sham, received saline 0.9% intraperitoneally (IP); lithium (Li), received a single IP injection of lithium chloride (LiCl) 80 mg/kg body weight (BW); glycerol (Gly), received a single dose of glycerol 50% 5 mL/kg BW intramuscular (IM); glycerol plus lithium (Gly+Li), received a single dose of glycerol 50% IM plus LiCl IP injected 2 hours after glycerol administration. After 24 hours, we performed inulin clearance experiments and collected blood / kidney / muscle samples. Gly rats exhibited renal function impairment accompanied by kidney injury, inflammation and alterations in signaling pathways for apoptosis and redox state balance. Gly+Li rats showed a remarkable improvement in renal function as well as kidney injury score, diminished CPK levels and an overstated decrease of renal and muscle GSK3β protein expression. Furthermore, administration of lithium lowered the amount of macrophage infiltrate, reduced NFκB and caspase renal protein expression and increased the antioxidant component MnSOD. Lithium treatment attenuated renal dysfunction in rhabdomyolysis-associated AKI by improving inulin clearance and reducing CPK levels, inflammation, apoptosis and oxidative stress. These therapeutic effects were due to the inhibition of GSK3β and possibly associated with a decrease in muscle injury.
first_indexed 2024-04-10T09:30:33Z
format Article
id doaj.art-111ad5e8be3a41ccb42388f08fea3ac4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-10T09:30:33Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-111ad5e8be3a41ccb42388f08fea3ac42023-02-19T05:31:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01182Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in ratsMaria Heloisa Massola ShimizuRildo Aparecido VolpiniAna Carolina de BragançaMariana Moura NascimentoDesiree Rita Denelle BernardoAntonio Carlos SeguroDaniele CanaleRhabdomyolysis is characterized by muscle damage and leads to acute kidney injury (AKI). Clinical and experimental studies suggest that glycogen synthase kinase 3β (GSK3β) inhibition protects against AKI basically through its critical role in tubular epithelial cell apoptosis, inflammation and fibrosis. Treatment with a single dose of lithium, an inhibitor of GSK3β, accelerated recovery of renal function in cisplatin and ischemic/reperfusion-induced AKI models. We aimed to evaluate the efficacy of a single dose of lithium in the treatment of rhabdomyolysis-induced AKI. Male Wistar rats were allocated to four groups: Sham, received saline 0.9% intraperitoneally (IP); lithium (Li), received a single IP injection of lithium chloride (LiCl) 80 mg/kg body weight (BW); glycerol (Gly), received a single dose of glycerol 50% 5 mL/kg BW intramuscular (IM); glycerol plus lithium (Gly+Li), received a single dose of glycerol 50% IM plus LiCl IP injected 2 hours after glycerol administration. After 24 hours, we performed inulin clearance experiments and collected blood / kidney / muscle samples. Gly rats exhibited renal function impairment accompanied by kidney injury, inflammation and alterations in signaling pathways for apoptosis and redox state balance. Gly+Li rats showed a remarkable improvement in renal function as well as kidney injury score, diminished CPK levels and an overstated decrease of renal and muscle GSK3β protein expression. Furthermore, administration of lithium lowered the amount of macrophage infiltrate, reduced NFκB and caspase renal protein expression and increased the antioxidant component MnSOD. Lithium treatment attenuated renal dysfunction in rhabdomyolysis-associated AKI by improving inulin clearance and reducing CPK levels, inflammation, apoptosis and oxidative stress. These therapeutic effects were due to the inhibition of GSK3β and possibly associated with a decrease in muscle injury.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934413/?tool=EBI
spellingShingle Maria Heloisa Massola Shimizu
Rildo Aparecido Volpini
Ana Carolina de Bragança
Mariana Moura Nascimento
Desiree Rita Denelle Bernardo
Antonio Carlos Seguro
Daniele Canale
Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats
PLoS ONE
title Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats
title_full Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats
title_fullStr Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats
title_full_unstemmed Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats
title_short Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats
title_sort administration of a single dose of lithium ameliorates rhabdomyolysis associated acute kidney injury in rats
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934413/?tool=EBI
work_keys_str_mv AT mariaheloisamassolashimizu administrationofasingledoseoflithiumamelioratesrhabdomyolysisassociatedacutekidneyinjuryinrats
AT rildoaparecidovolpini administrationofasingledoseoflithiumamelioratesrhabdomyolysisassociatedacutekidneyinjuryinrats
AT anacarolinadebraganca administrationofasingledoseoflithiumamelioratesrhabdomyolysisassociatedacutekidneyinjuryinrats
AT marianamouranascimento administrationofasingledoseoflithiumamelioratesrhabdomyolysisassociatedacutekidneyinjuryinrats
AT desireeritadenellebernardo administrationofasingledoseoflithiumamelioratesrhabdomyolysisassociatedacutekidneyinjuryinrats
AT antoniocarlosseguro administrationofasingledoseoflithiumamelioratesrhabdomyolysisassociatedacutekidneyinjuryinrats
AT danielecanale administrationofasingledoseoflithiumamelioratesrhabdomyolysisassociatedacutekidneyinjuryinrats